CAR-T immunotherapy is changing the way we think about cancer treatment. Early and impressive clinical success of this emerging therapy is driving a revolution in the cell and gene therapy industry. Developers are rushing to solve technical hurdles, drive down costs, and make this therapy widely available.

In this highly competitive space, how can you stand out from the crowd and develop a more effective CAR-T therapy? The answer is simple: access to the newest technologies. In this poster you will discover how your CAR-T therapy can be advanced by developing closed systems. This poster will explore:

  • Commercially available regents that improve process efficiency
  • Equipment that can reduce manual manipulation time
  • How automation can reduce open operations

If you are looking to better understand how system closure can advance CAR-T therapies, this resource may help create a more effective CAR-T therapy.